Page last updated: 2024-10-29

imipramine and Lesch-Nyhan Syndrome

imipramine has been researched along with Lesch-Nyhan Syndrome in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Lesch-Nyhan Syndrome: An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nyhan, WL1
Johnson, HG1
Kaufman, IA1
Jones, KL1

Other Studies

1 other study available for imipramine and Lesch-Nyhan Syndrome

ArticleYear
Serotonergic approaches to the modification of behavior in the Lesch-Nyhan Syndrome.
    Applied research in mental retardation, 1980, Volume: 1, Issue:1-2

    Topics: 5-Hydroxytryptophan; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Humans; Imipramine; Lesc

1980